T1a and T1b breast cancer: A twelve-year experience

American Surgeon

Volumn 63, Issue 7, 1997, Pages 621-626

  Visser, Thomas J ^a   Haan, Mark ^a   Keidan, Richard ^a   Lucas, Robert ^a   Ingold, John ^a   Glover, John ^a   Riggo, Paul ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; CELL TYPE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; TUMOR VOLUME;

ADULT; AGE FACTORS; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MENOPAUSE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031007523     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ruffin WK, Stacey-Clear A, Younger J, Hoover HC. Rationale for routine axillary disection in carcinoma of the breast. J Am Coll Surg 1995;180:245-51.
2. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma: Is it indicated? Cancer 1994;73:664-7.
3. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;73:505-8.
4. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;218:338-49.
5. Haffy BG, McKhann C, Beinfield M, et al. Breast conservation without axillary dissection: A rational treatment strategy in selective patients. AMA Arch Surg 1993;128:1315-9.
6. Wazer DE, Erban JK, Robert NJ, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 1994;74:878-83.
7. Sunderland MC, McGuire WL. Prognostic indicators in invasive breast cancer. Surg Clin North Am 1990;70:989-1004.
8. Stierer M, Rosen HR, Weber R, et al. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol & Obstet 1992;175: 151-60.
9. O'Reilly SM, Camplejohn RS, Barnes DM, et al. Node negative breast cancer: Prognosis subgroups defined by tumor size and flow cytometry. J Clin Oncol 1990;8:2040-6.
10. Yamashita J, Ogawa M, Sakai K. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node negative breast cancer. Surgery 1995;117:601-8.
11. Menard S, Bufalino R, Reike F, et al. Prognosis based on primary breast carcinoma instead of pathologic node status. Br J Cancer 1994;70:709-12.
12. Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 1989;157:501-2.
13. Chadha M, Chaleon A, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancers: A multivariate analysis. Cancer 1994;73:350-3.
14. Seidman JD, Schnapper LA, Aisner S. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis. Cancer 1995;75:65-71.
15. Kambouris A. Axillary node metastases in relation to size and location of breast cancers: Analysis of 147 patients. Am Surg 1996;62:519-24.
16. Silverstein MJ, Geirson ED, Waisman JR, et al. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 1995;180:700-4.
17. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-81.
18. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1977;39:2827-39.
19. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131:301-8.
20. Steele RJC, Forrest APM, Gibson T, et al. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial. Br J Surg 1985;72:368-9.
21. Fisher B. The surgical dilema in the primary therapy of invasive breast cancer: A critical appraisal. Curr Probl Surg 1970(Oct);1-53.
22. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21.
23. Chung M, Chang H, Bland K, Wanebo H. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77:97-103.
24. Fowble B, Delray SJ, Overmoyer B, et al. The influence of young age on outcome in early stage breast cancer. J Radiat Oncol Biol Phys 1994;30:23-32.
25. Fisher B, Slack N, Katrych D, Wolmark N. Ten-year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol & Obstet 1975;140:528-34.
26. Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-24.
27. NIH Consensus Conference. Adjuvant chemotherapy for breast cancer. JAMA 1985;254:3461-3.